206 related articles for article (PubMed ID: 1914267)
1. Effects of sublingual nitroglycerin in patients receiving transdermal nitroglycerin for coronary artery disease: prevention of cross-tolerance.
Naito H; Matsuda Y; Yorozu T; Shiomi K; Maeda T; Seki K; Tada T; Fujii H
Clin Cardiol; 1991 Aug; 14(8):644-50. PubMed ID: 1914267
[TBL] [Abstract][Full Text] [Related]
2. Differences of intravenous nitroglycerin responses in left ventricular systolic and end-diastolic pressures and coronary artery diameters during long-term treatment with cutaneous nitroglycerin patches.
Naito H; Matsuda Y; Yorozu T; Maeda T; Tada T; Shiomi K
Clin Cardiol; 1993 Feb; 16(2):123-7. PubMed ID: 8435925
[TBL] [Abstract][Full Text] [Related]
3. Effects of dosing intervals on the development of tolerance to high dose transdermal nitroglycerin.
Nabel EG; Barry J; Rocco MB; Mead K; Selwyn AP
Am J Cardiol; 1989 Mar; 63(11):663-9. PubMed ID: 2493732
[TBL] [Abstract][Full Text] [Related]
4. Sublingual nitroglycerin administered by spray versus tablet: comparative timing of hemodynamic effects.
Laslett LJ; Baker L
Cardiology; 1990; 77(4):303-10. PubMed ID: 2127377
[TBL] [Abstract][Full Text] [Related]
5. Long-term efficacy of continuous and intermittent use of transdermal nitroglycerin in stable angina pectoris.
de Milliano PA; Koster RW; Bär FW; Janssen J; de Cock C; Schelling A; van de Bos A
Am J Cardiol; 1991 Oct; 68(9):857-62. PubMed ID: 1927943
[TBL] [Abstract][Full Text] [Related]
6. Effect of therapy with an angiotensin-converting enzyme inhibitor on hemodynamic and counterregulatory responses during continuous therapy with nitroglycerin.
Parker JD; Parker JO
J Am Coll Cardiol; 1993 May; 21(6):1445-53. PubMed ID: 8473654
[TBL] [Abstract][Full Text] [Related]
7. Acute and chronic antianginal efficacy of continuous twenty-four-hour application of transdermal nitroglycerin. Steering Committee, Transdermal Nitroglycerin Cooperative Study.
Am J Cardiol; 1991 Nov; 68(13):1263-73. PubMed ID: 1951111
[TBL] [Abstract][Full Text] [Related]
8. Rapid coronary vasodilation by nitroglycerin tapes.
Hara M; Saikawa T; Tsunematsu Y; Maeda T; Inoue T; Koumatsu K; Ito K; Nawata T; Sakata T
Jpn Heart J; 1996 Sep; 37(5):603-10. PubMed ID: 8973374
[TBL] [Abstract][Full Text] [Related]
9. Active and passive coronary vasodilation after intracoronary and sublingual nitroglycerin.
Schulz W; von Anderten W; Reiber JH; Bernauer R; Kaltenbach M; Kober G
Z Kardiol; 1983; 72 Suppl 3():82-6. PubMed ID: 6421018
[TBL] [Abstract][Full Text] [Related]
10. [The development of tolerance to continuous transdermal nitroglycerin therapy in patients with angina of effort and mixed angina].
Cianfrocca C; Sabia R; Zoboli S; Bugiardini R
G Ital Cardiol; 1993 May; 23(5):439-49. PubMed ID: 8339869
[TBL] [Abstract][Full Text] [Related]
11. Effects of sublingual nitrate in patients receiving sustained therapy of isosorbide dinitrate for coronary artery disease.
Naito H; Matsuda Y; Shiomi K; Yorozu T; Maeda T; Lee H; Seki K; Nakashima H
Am J Cardiol; 1989 Sep; 64(10):565-8. PubMed ID: 2782246
[TBL] [Abstract][Full Text] [Related]
12. [Administration of nitroglycerin using transdermal patches].
Kulbertus H
Rev Med Liege; 1997 Nov; 52(11):709-11. PubMed ID: 9480496
[No Abstract] [Full Text] [Related]
13. Effect of glyceryl trinitrate on coronary and systemic hemodynamics in man.
Conti CR; Feldman RL; Pepine CJ; Hill JA; Conti JB
Am J Med; 1983 Jun; 74(6B):28-32. PubMed ID: 6407313
[TBL] [Abstract][Full Text] [Related]
14. [Effect of nitroglycerin on coronary artery dilatation and hemodynamics: comparison among sublingual, intravenous, and intra-coronary administration].
Suwa J; Miyazawa Y; Tanaka T; Umemura J; Miura M; Hisa S; Nakano J; Kusumoto M; Komatsu Y
Kokyu To Junkan; 1986 Oct; 34(10):1087-91. PubMed ID: 3099354
[No Abstract] [Full Text] [Related]
15. Influence of captopril on nitroglycerin-mediated vasodilation and development of nitrate tolerance in arterial and venous circulation.
Pizzulli L; Hagendorff A; Zirbes M; Fehske W; Ewig S; Jung W; Lüderitz B
Am Heart J; 1996 Feb; 131(2):342-9. PubMed ID: 8579031
[TBL] [Abstract][Full Text] [Related]
16. Vasoconstriction of stenotic coronary arteries during dynamic exercise in patients with classic angina pectoris: reversibility by nitroglycerin.
Gage JE; Hess OM; Murakami T; Ritter M; Grimm J; Krayenbuehl HP
Circulation; 1986 May; 73(5):865-76. PubMed ID: 3084124
[TBL] [Abstract][Full Text] [Related]
17. Randomized Trial Comparing Transdermal With Sublingual Nitroglycerin Administration for Coronary Vasodilation in CTA.
Scholtz JE; Baliyan V; Hedgire S; Mercaldo ND; Pierce TT; Missine GZS; Meyersohn NM; Stockton K; Redel TL; McNulty F; Savage C; Roberts RJ; Foldyna B; Takx RAP; Dushyant S; Lu MT; Hoffmann U; Ghoshhajra BB
JACC Cardiovasc Imaging; 2019 Sep; 12(9):1890-1893. PubMed ID: 31103580
[No Abstract] [Full Text] [Related]
18. Nitroglycerin in chronic stable angina pectoris.
Reichek N
Am J Cardiol; 1987 Nov; 60(15):15H-17H. PubMed ID: 3120561
[TBL] [Abstract][Full Text] [Related]
19. Coronary stenosis dilation by low dose intravenous nitroglycerin.
Sievert H; Selzer G; Schneider W; Kober G; Kaltenbach M; Bussmann WD
Eur Heart J; 1989 Nov; 10 Suppl F():134-6. PubMed ID: 2515967
[TBL] [Abstract][Full Text] [Related]
20. Role of short-acting nitroglycerin in the management of ischemic heart disease.
Boden WE; Padala SK; Cabral KP; Buschmann IR; Sidhu MS
Drug Des Devel Ther; 2015; 9():4793-805. PubMed ID: 26316714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
